| Sheikh Habibullah, MD | |
|
1702 University Dr S, Fargo, ND 58103-4940 | |
| (701) 364-8000 | |
| Not Available |
| Full Name | Sheikh Habibullah |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 13 Years |
| Location | 1702 University Dr S, Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255827457 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 18351 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Essentia Health | Fargo, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Innovis Health Llc | 9931298155 | 473 |
News Archive
New research highlights how nerves - whether harmed by disease or traumatic injury - start to die, a discovery that unveils novel targets for developing drugs to slow or halt peripheral neuropathies and devastating neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS).
Researchers from the Harvard affiliated Hebrew SeniorLife Institute for Aging Research, in collaboration with scientists from Beth Israel Deaconess Medical Center, Harvard Medical School, and Brown University, have found increasing evidence that the level of delirium in post-surgical patients is associated with the level of later cognitive decline in those same patients.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1b trial of ViaDor-GLP1 agonist, which is being developed for the treatment of diabetes mellitus type II.
Columbia University Medical Center researchers have captured the first three-dimensional snapshots of the AMPA-subtype glutamate receptor in action. The receptor, which regulates most electrical signaling in the brain, is involved in several important brain activities, including memory and learning.
The cost-effectiveness of using complementary treatments in the United Kingdom has been the subject of much speculation and controversy.
› Verified 9 days ago
| Entity Name | Innovis Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215125463 PECOS PAC ID: 9931298155 Enrollment ID: O20071211000158 |
News Archive
New research highlights how nerves - whether harmed by disease or traumatic injury - start to die, a discovery that unveils novel targets for developing drugs to slow or halt peripheral neuropathies and devastating neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS).
Researchers from the Harvard affiliated Hebrew SeniorLife Institute for Aging Research, in collaboration with scientists from Beth Israel Deaconess Medical Center, Harvard Medical School, and Brown University, have found increasing evidence that the level of delirium in post-surgical patients is associated with the level of later cognitive decline in those same patients.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1b trial of ViaDor-GLP1 agonist, which is being developed for the treatment of diabetes mellitus type II.
Columbia University Medical Center researchers have captured the first three-dimensional snapshots of the AMPA-subtype glutamate receptor in action. The receptor, which regulates most electrical signaling in the brain, is involved in several important brain activities, including memory and learning.
The cost-effectiveness of using complementary treatments in the United Kingdom has been the subject of much speculation and controversy.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sheikh Habibullah, MD 1702 University Dr S, Fargo, ND 58103-4940 Ph: (701) 364-8000 | Sheikh Habibullah, MD 1702 University Dr S, Fargo, ND 58103-4940 Ph: (701) 364-8000 |
News Archive
New research highlights how nerves - whether harmed by disease or traumatic injury - start to die, a discovery that unveils novel targets for developing drugs to slow or halt peripheral neuropathies and devastating neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS).
Researchers from the Harvard affiliated Hebrew SeniorLife Institute for Aging Research, in collaboration with scientists from Beth Israel Deaconess Medical Center, Harvard Medical School, and Brown University, have found increasing evidence that the level of delirium in post-surgical patients is associated with the level of later cognitive decline in those same patients.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1b trial of ViaDor-GLP1 agonist, which is being developed for the treatment of diabetes mellitus type II.
Columbia University Medical Center researchers have captured the first three-dimensional snapshots of the AMPA-subtype glutamate receptor in action. The receptor, which regulates most electrical signaling in the brain, is involved in several important brain activities, including memory and learning.
The cost-effectiveness of using complementary treatments in the United Kingdom has been the subject of much speculation and controversy.
› Verified 9 days ago
Susan L Scarberry, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 700 1st Ave S, Fargo, ND 58103 Phone: 701-234-4036 Fax: 701-234-4160 | |
Charlotte Marie Andersen, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 510 4th Street S, Fargo, ND 58107 Phone: 701-476-7200 | |
Dr. Lawana Marie Burtnett, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 510 4th St S, Fargo, ND 58103 Phone: 701-476-7200 | |
Dr. Ravinda Samaraweera, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 700 1st Ave S, Fargo, ND 58103 Phone: 701-234-4036 Fax: 701-234-4160 | |
Dr. Timothy T Vo, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2624 9th Ave S, Southeast Human Service Center, Fargo, ND 58103 Phone: 701-298-4500 Fax: 701-298-4400 | |
Karis Antonia Stenback Irving, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2101 Elm St Ne, Fargo, ND 58102 Phone: 615-918-0639 Fax: 612-749-3990 | |
Amna Masood, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 736 Broadway N, Fargo, ND 58102 Phone: 701-234-2000 Fax: 701-234-2345 |